CHEK1 and breast cancer: However, enhanced DDR activity is reported in many dormant cancer cells, including BC [136], such that DDR signalling, particularly the ATR-Chk1 pathway (a key DDR mechanism) in a cohort of invasive BC patients, was shown to be predictive of early local and distant recurrence [140].